Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritis
Objectives Despite several effective targeted therapies, biomarkers that predict whether a patient with psoriatic arthritis (PsA) will respond to a particular treatment are currently lacking.Methods We analysed proteomics data from serum samples of nearly 2000 patients with PsA in placebo-controlled...
Main Authors: | Richard M Siegel, Marc Vandemeulebroecke, Mathias Cardner, Danny Tuckwell, Anna Kostikova, Pascal Forrer, Alain Marti, Enrico Ferrero |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-04-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/9/2/e003042.full |
Similar Items
-
Comparison of the effects of antihypertensive treatment with angiotensin II blockade and beta-blockade on carotid wall structure and haemodynamics: protocol and baseline demographics
by: Ben Ariff, et al.
Published: (2002-06-01) -
Status of beta defensin-1 in Indian goat breeds
by: R RANJAN, et al.
Published: (2019-11-01) -
Improving Fmoc Solid Phase Synthesis of Human Beta Defensin 3
by: Aleksandra Walewska, et al.
Published: (2022-10-01) -
Serum levels of antimicrobial peptides (Cathelicidins and Beta Defensins-1) in patients with periodontitis
by: Fatima Z Al-Daragi, et al.
Published: (2024-03-01) -
Correction: Identification, Expression and Activity Analyses of Five Novel Duck Beta-Defensins
Published: (2013-01-01)